Mazars supported Niks Professional in its successful IPO

Mazars in Singapore is proud to have supported Niks Professional, a Singapore-based provider of dermatology and aesthetic medical services, in their successful Initial Public Offering (IPO) listing on the Catalist board of the Singapore Exchange (SGX) on 27 October 2023.

Founded in 1998, Niks Professional currently operates three clinics and three retail outlets in Singapore, in addition to conducting business-to-business operations in China.

This IPO involved the issuance of 21.8 million new shares, which represented a significant 16.8 percent of the company's expanded share capital. The IPO was 5.9 times oversubscribed, showcasing the robust interest in Niks Professional's offering. Of the 21.8 million shares issued, one million were made available to the public, while the remaining 20.8 million were designated as placement shares, attracting a 1.6 times oversubscription.

This engagement was led by Mazars in Singapore's Risk Consulting & Sustainability services team, featuring the expertise of the following key members who conducted a comprehensive pre-IPO internal control review:

  • Chester Liew, Partner
  • Damien Yong, Associate Director

Mazars in Singapore is honored to have been a part of this exciting journey and look forward to witnessing Niks Professional's continued success in the future.Top of Form

This marks yet another successful capital market project that Mazars in Singapore has participated, building upon the comprehensive range of services provided by our capital market team.

1FB_03.jpg2WhatsApp-Image-2023-10-27-at-13.05.55.jpg
1FB_03.jpg2WhatsApp-Image-2023-10-27-at-13.05.55.jpg

Our experts